Most frequent bacterial agents and antimicrobal therapy in patients with different types of acute exacerbation of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 337s Year: 2003
Lung function in patients with different infecting agents caused acute exacerbation of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 337s Year: 2003
Microorganisms resistant to conventional antimicrobial treatment in acute exacerbation of COPD Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes Year: 2017
Role of viruses and atypical agents in COPD acute exacerbations Source: Eur Respir J 2004; 24: Suppl. 48, 408s Year: 2004
The investigation of infectious agents and their antibiotic sensitivities in COPD exacerbations Source: Eur Respir J 2006; 28: Suppl. 50, 3s Year: 2006
Frequency of revealing of infectious agents in children with chronic cough Source: Eur Respir J 2007; 30: Suppl. 51, 391s Year: 2007
Comparative evaluation of fluoroquinolone efficiency in treatment of infectious acute attack of chronic obstructive bronchitis Source: Eur Respir J 2004; 24: Suppl. 48, 512s Year: 2004
Quinolones to treat acute bacterial exacerbation of chronic bronchitis in TB endemic areas: a word of caution Source: Eur Respir J 2007; 30: 1233 Year: 2007
How resistance is changing the etiology of acute and chronic respiratory infections? Source: International Congress 2015 – Antibiotic resistance in respiratory infections Year: 2015
Presence of bacterial infection influences the severity of symptoms in acute COPD exacerbations Source: Eur Respir J 2002; 20: Suppl. 38, 261s Year: 2002
Atypical respiratory pathogens in severe COPD exacerbations Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment Year: 2009
Correlation between sputum colour and isolation of an infecting organism in patients with acute exacerbations of chronic bronchitis (AECB) Source: Annual Congress 2007 - Aetiology, mechanisms and treatment in lower respiratory tract infections Year: 2007
Antibacterial activity of telithromycin and comparators against pathogens isolated from patients with acute exacerbations of chronic bronchitis (AECB) in PROTEKT years 1–5 (1999–2004) Source: Annual Congress 2006 - Clinical aspects and treatment of lower respiratory infection in COPD patients Year: 2006
New rhinovirus strains predominate in children with acute asthma and are associated with more severe exacerbations Source: Annual Congress 2009 - How viruses, allergic rhinitis and air pollution affect childhood asthma Year: 2009
Bacterial infections in patients with acute exacerbations of COPD Source: Eur Respir J 2004; 24: Suppl. 48, 639s Year: 2004
Clinical evaluation of patients with acute exacerbation of chronic bronchitis treated emperically with telithromycin Source: Eur Respir J 2004; 24: Suppl. 48, 638s Year: 2004
Incidence of different pathogenic microorganisms and antibiotic susceptibility in a respiratory diseases unit Source: Eur Respir J 2004; 24: Suppl. 48, 638s Year: 2004
Clinical relevance of respiratory pathogens in patients hospitalised with acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2013 –Interesting cases of respiratory infections Year: 2013
New clinical perspectives in AECB Source: Annual Congress 2005 - Antibiotic therapy: short- and long-term outcomes in LRTI Year: 2005
Why short-term antibiotic use in AECB may influence long-term outcomes Source: Annual Congress 2005 - Antibiotic therapy: short- and long-term outcomes in LRTI Year: 2005